Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
389.50
-1.50 (-0.38%)
Feb 11, 2026, 1:21 PM CST
Market Cap21.30B +38.7%
Revenue (ttm)2.00B +14.6%
Net Income716.94M +2.6%
EPS13.15 +2.6%
Shares Out54.46M
PE Ratio29.73
Forward PEn/a
Dividend11.60 (2.97%)
Ex-Dividend DateAug 4, 2025
Volume20,185
Average Volume7,547
Open393.50
Previous Close391.00
Day's Range389.50 - 393.50
52-Week Range274.00 - 501.00
Beta-0.16
RSI45.86
Earnings DateMar 16, 2026

About Sunmax Biotechnology

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4728
Full Company Profile

Financial Performance

In 2024, Sunmax Biotechnology's revenue was 1.82 billion, an increase of 7.64% compared to the previous year's 1.69 billion. Earnings were 679.41 million, an increase of 8.58%.

Financial Statements